Artificial protein coronas: directing nanoparticles to targets

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• The protein corona on nanoparticles (NPs) is crucial for targeted drug delivery.
• Studying in vivo corona-receptor interactions is challenging due to in vitro limitations.

Purpose of the Study:

• To propose engineered protein coronas as a solution for studying in vivo nanoparticle-protein interactions.
• To introduce quartz crystal microbalance (QCM) as a method for assessing these interactions.
• To outline future experiments for optimizing NP-based drug delivery.

Main Methods:

• Utilizing engineered protein coronas composed of selected plasma proteins.
• Employing adapted quartz crystal microbalance (QCM) setups to analyze corona-receptor interactions.
• Critically discussing the limitations and advancements of QCM technology.

Main Results:

• Engineered protein coronas maintain their properties in vivo, allowing for specific receptor targeting.
• QCM setups can be adapted to study complex in vivo interactions.
• Proposed future experiments aim to decipher corona-receptor interactions.

Conclusions:

• Engineered protein coronas provide a viable strategy to overcome in vitro limitations in studying NP-protein interactions.
• QCM technology holds potential for advancing the understanding of these interactions.
• Further research can unlock the full therapeutic potential of protein coronas in drug delivery.